These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9556072)

  • 1. Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume.
    Pfeilschifter J; Diel I; Scheppach B; Bretz A; Krempien R; Erdmann J; Schmid G; Reske N; Bismar H; Seck T; Krempien B; Ziegler R
    J Bone Miner Res; 1998 Apr; 13(4):716-30. PubMed ID: 9556072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant TGF-beta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice.
    Gazit D; Zilberman Y; Turgeman G; Zhou S; Kahn A
    J Cell Biochem; 1999 Jun; 73(3):379-89. PubMed ID: 10321837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta 1 (TGF-beta1) prevents the age-dependent decrease in bone formation in human osteoblast/implant cultures.
    Zhang H; Aronow MS; Gronowicz GA
    J Biomed Mater Res A; 2005 Oct; 75(1):98-105. PubMed ID: 16044414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
    Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term ovarian hormone deficiency on transforming growth factor-beta and bone matrix protein mRNA expression in rat femora.
    Westerlind KC; Wronski TJ; Evans GL; Turner RT
    Biochem Biophys Res Commun; 1994 Apr; 200(1):283-9. PubMed ID: 8166696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
    Sterck JG; Klein-Nulend J; Burger EH; Lips P
    J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients.
    Truong LH; Kuliwaba JS; Tsangari H; Fazzalari NL
    Arthritis Res Ther; 2006; 8(6):R188. PubMed ID: 17187661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
    Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
    Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
    Fromigué O; Marie PJ; Lomri A
    J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.
    Harris SE; Bonewald LF; Harris MA; Sabatini M; Dallas S; Feng JQ; Ghosh-Choudhury N; Wozney J; Mundy GR
    J Bone Miner Res; 1994 Jun; 9(6):855-63. PubMed ID: 8079661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs.
    Seck T; Scheppach B; Scharla S; Diel I; Blum WF; Bismar H; Schmid G; Krempien B; Ziegler R; Pfeilschifter J
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2331-7. PubMed ID: 9661604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture.
    Chen TL; Bates RL
    J Bone Miner Res; 1993 Apr; 8(4):423-34. PubMed ID: 8475792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6, transforming growth factor-beta 1, and bone markers after kidney transplantation.
    Kusec V; Smalcelj R; Puretic Z; Szekeres T
    Calcif Tissue Int; 2004 Jul; 75(1):1-6. PubMed ID: 15037969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary characterization of porcine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta, and basic fibroblast growth factor.
    Thomson BM; Bennett J; Dean V; Triffitt J; Meikle MC; Loveridge N
    J Bone Miner Res; 1993 Oct; 8(10):1173-83. PubMed ID: 8256654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and amplification of a bone marrow cell population and its induction to the chondro-osteogenic lineage by rhOP-1: an in vitro and in vivo study.
    Andrades JA; Santamaría JA; Nimni ME; Becerra J
    Int J Dev Biol; 2001 Jun; 45(4):689-93. PubMed ID: 11461007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High bone matrix turnover predicts blood levels of lead among perimenopausal women.
    Machida M; Sun SJ; Oguma E; Kayama F
    Environ Res; 2009 Oct; 109(7):880-6. PubMed ID: 19595303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.